Welcome to Novo Nordisk in the United States

Policy and Advocacy

We believe that early detection and quality care are the elements necessary to extend and improve the lives of people living with diabetes, hemophilia, obesity and growth hormone disorders. Our mission is to inform and influence policy to promote access to care for the patients we serve and to communicate the impact of healthcare reform.

Through our Measure, Educate and Advocate framework, and in collaboration with federal agencies, policymakers, advocacy organizations and other internal and external stakeholders, we make it our goal to promote evidence-based prevention, detection and treatment efforts to ultimately turn best practices into public policy.



Learn more


Learn more


Learn more